[Development of a novel anti-cancer therapy based on targeting of tumor microvessel endothelial cells].
Tsuno
Hirokazu
H
Department of Tranfusion Medicine and Immunoheamtology, The University of Tokyo.
Okaji
Yurai
Y
Tanaka
Minoru
M
Nagawa
Hirokazu
H
Takahashi
Koki
K
D000818:Animals; D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D019496:Cancer Vaccines; D002478:Cells, Cultured; D016503:Drug Delivery Systems; D000071063:Endoglin; D042783:Endothelial Cells / Q000276:immunology / Q000473:pathology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000098:blood supply* / Q000276:immunology / Q000628:therapy*; D009389:Neovascularization, Pathologic; D011956:Receptors, Cell Surface; D014471:Umbilical Veins / Q000166:cytology / Q000276:immunology; D019010:Vascular Cell Adhesion Molecule-1 / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D019496:Cancer Vaccines; C064206:ENG protein, human; D000071063:Endoglin; D011956:Receptors, Cell Surface; D019010:Vascular Cell Adhesion Molecule-1